Search clinical trials for: LN-144
Total 406 results
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Iovance Biotherapeutics, Inc.No longer availableMetastatic Melanoma | Unresectable MelanomaUnited States
-
Iovance Biotherapeutics, Inc.RecruitingSquamous Cell Carcinoma of the Head and Neck | Metastatic Melanoma | Non-small Cell Lung CancerUnited States, Spain, Canada, France, Germany, Greece, Switzerland, United Kingdom
-
Richard WuIovance Biotherapeutics, Inc.Active, not recruitingLocally Advanced Melanoma | Stage IV Melanoma | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States
-
University of Sao PauloUnknownCritical Illness | HypernatremiaBrazil
-
Orion Corporation, Orion PharmaCompleted
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, France, Netherlands, Italy, Canada, Sweden
-
James Isaacs, MDNot yet recruitingStage IIIB Melanoma | Stage IIIC Melanoma | Stage IIID MelanomaUnited States
-
Iovance Biotherapeutics, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Changchun GeneScience Pharmaceutical Co., Ltd.Recruiting
-
Changchun GeneScience Pharmaceutical Co., Ltd.Syneos HealthRecruitingVasomotor Symptoms | Adult Healthy VolunteersAustralia
-
University of FloridaCompletedProstate CancerUnited States
-
Institut Cancerologie de l'OuestDirection Générale de l'Offre de SoinsTerminatedInvasive Breast Cancer | Sentinel Lymph Node Biopsy | Ipsilateral RecurrenceFrance
-
HI-BioRecruitingLupus NephritisUnited States, Argentina, Australia
-
IlDong Pharmaceutical Co LtdUnknown
-
Vedic Lifesciences Pvt. Ltd.Completed
-
Avilex PharmaCompletedTolerance | Safety IssuesFinland
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
The First Affiliated Hospital of Dalian Medical...Unknown
-
AmgenCompletedHealthy ParticipantsUnited States
-
Lukas J HefermehlKantonsspital BadenRecruitingRenal TumorSwitzerland
-
Eli Lilly and CompanyCoLucid PharmaceuticalsCompletedMigraine DisordersBelgium, Germany, France, Spain, Finland
-
Philip Morris Products S.A.Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Albert Einstein College of MedicineRecruiting
-
Novartis PharmaceuticalsActive, not recruitingLupus NephritisTaiwan
-
Asan Medical CenterLN RoboticsRecruitingPercutaneous Coronary InterventionKorea, Republic of
-
RenJi HospitalNot yet recruitingWhether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de MontréalCompletedNeoplasm of Mediastinal Lymph NodesCanada
-
TakedaCompletedPremenopausal Breast CancerJapan
-
Nan ShenNovartisNot yet recruitingCharacterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to Soc | Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype | Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring
-
University Hospital, GhentRecruitingObsessive-Compulsive DisorderBelgium
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
Merck Sharp & Dohme LLCTerminatedAdvanced Pancreatic Adenocarcinoma
-
TakedaCompleted
-
Universidad de AntioquiaARTMEDICAWithdrawnLupus Nephritis
-
Zhejiang Cancer HospitalCompletedNon-small Cell Lung Cancer
-
Mei-fang HuangUnknownTo Investigate the Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone ApplicationTaiwan
-
Daewoong Pharmaceutical Co. LTD.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.Active, not recruitingMalignant Solid Neoplasm | Soft Tissue Sarcoma | Recurrent Ovarian Carcinoma | Triple Negative Breast Cancer | Recurrent Osteosarcoma | Refractory Osteosarcoma | Bone Sarcoma | Giant Cell Tumor of Bone | Ovarian Carcinosarcoma | Platinum-Resistant Ovarian Carcinoma | Dedifferentiated Chondrosarcoma | Malignancy... and other conditionsUnited States
-
The University of Hong KongNot yet recruitingChronic Kidney Diseases | Lupus NephritisHong Kong
-
General Hospital of Ningxia Medical UniversityRecruitingPostoperative Delirium | ElectroencephalogramChina
-
ISDINDigna Biotech S.L.CompletedSkin FibrosisUnited Kingdom, Spain, Italy, Poland, Germany, Hungary
-
Iovance Biotherapeutics, Inc.RecruitingCervical CarcinomaUnited States, Spain, United Kingdom, Germany, France, Italy, Netherlands, Switzerland